Seres Therapeutics
MCRB
MCRB
77 hedge funds and large institutions have $258M invested in Seres Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 91 → 77 (-14)
64% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 22
Holders
77
Holding in Top 10
1
Calls
$1.23M
Puts
$160K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$11.3M | |
| 3 | +$6.73M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.65M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.1M |
Top Sellers
| 1 | -$8.05M | |
| 2 | -$3.82M | |
| 3 | -$3.13M | |
| 4 |
Goldman Sachs
New York
|
-$2.06M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.53M |